Literature DB >> 1673994

Alterations in cortical [3H]kainate and alpha-[3H]amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid binding in a spontaneous canine model of chronic hepatic encephalopathy.

J E Maddison1, W E Watson, P R Dodd, G A Johnston.   

Abstract

Excitatory amino acid receptor binding parameters were investigated in a spontaneous dog model of chronic hepatic encephalopathy. L-[3H]Glutamate, (+)-[3H]-5-methyl-10,11-dihydro-5H-dibenzo[a,d]cyclohepten-5,10-im ine maleate ([3H]MK-801), [3H]kainate, and alpha-[3H]-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid ([3H]AMPA) binding experiments were performed using crude cerebrocortical synaptosomal membrane preparations from dogs with congenital portosystemic encephalopathy (PSE) and control dogs. There was no change in the affinity or density of L-[3H]-glutamate or [3H]MK-801 binding sites in dogs with congenital PSE compared with control dogs. However, in the PSE dogs there was a significant reduction in the density of [3H]kainate binding sites compared with control dogs and abolition of the low-affinity [3H]AMPA binding site. The relative binding capacity of PSE synaptosomal membranes for [3H]kainate and [3H]AMPA was expressed as the ratio Bmax/KD. There was a significant inverse correlation between the Bmax/KD ratio for [3H]AMPA binding and the worst grade of encephalopathy experienced by each dog. These results suggest that there is a significant perturbation of cerebrocortical non-N-methyl-D-aspartate receptor binding in dogs with congenital PSE which may have relevance to the pathogenesis of hepatic encephalopathy.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1673994     DOI: 10.1111/j.1471-4159.1991.tb03444.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  10 in total

1.  Ammonia-induced alterations in the metabolism of glutamate and aspartate in neuronal perikarya and synaptosomes of rat cerebellum.

Authors:  V L Rao; C R Murthy
Journal:  Metab Brain Dis       Date:  1992-03       Impact factor: 3.584

Review 2.  Pathogenesis and treatment of portal-systemic encephalopathy: an update.

Authors:  R F Butterworth
Journal:  Dig Dis Sci       Date:  1992-03       Impact factor: 3.199

Review 3.  Glutamatergic synaptic dysfunction in hyperammonemic syndromes.

Authors:  V L Rao; C R Murthy; R F Butterworth
Journal:  Metab Brain Dis       Date:  1992-03       Impact factor: 3.584

Review 4.  Neuronal nitric oxide synthase and Hepatic Encephalopathy.

Authors:  V L Rao; R F Butterworth
Journal:  Metab Brain Dis       Date:  1998-09       Impact factor: 3.584

5.  Neuroactive amino acids in hepatic encephalopathy.

Authors:  R F Butterworth
Journal:  Metab Brain Dis       Date:  1996-06       Impact factor: 3.584

Review 6.  Effects of hyperammonemia and liver failure on glutamatergic neurotransmission.

Authors:  Pilar Monfort; María-Dolores Muñoz; Amina ElAyadi; Elena Kosenko; Vicente Felipo
Journal:  Metab Brain Dis       Date:  2002-12       Impact factor: 3.584

7.  Binding of the ligand [3H]MK-801 to the MK-801 binding site of the N-methyl-D-aspartate receptor during experimental encephalopathy from acute liver failure and from acute hyperammonemia in the rabbit.

Authors:  R J de Knegt; J Kornhuber; S W Schalm; K Rusche; P Riederer; J Tan
Journal:  Metab Brain Dis       Date:  1993-06       Impact factor: 3.584

8.  CNQX binding to non-NMDA glutamate receptors in canine cerebro-cortical crude synaptosomal membranes: pharmacological characterization and comparison of binding parameters in dogs with congenital portosystemic encephalopathy and control dogs.

Authors:  J E Maddison; W E Watson; G A Johnston
Journal:  Metab Brain Dis       Date:  1992-03       Impact factor: 3.584

9.  Ammonia added in vitro, but not moderate hyperammonemia in vivo, stimulates glutamate uptake and H(+)-ATPase activity in synaptic vesicles of the rat brain.

Authors:  J Albrecht; W Hilgier; M Walski
Journal:  Metab Brain Dis       Date:  1994-09       Impact factor: 3.584

10.  Ammonium acetate inhibits ionotropic receptors and differentially affects metabotropic receptors for glutamate.

Authors:  G Lombardi; G Mannaioni; P Leonardi; G Cherici; V Carlà; F Moroni
Journal:  J Neural Transm Gen Sect       Date:  1994
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.